A licensed UK company offers commercial agency services to pharmaceutical companies specialising in oncology and speciality medicines for rare diseases that are interested in entering new markets. The special drugs/medicines should be commercially approved. The company is looking for commercial agency agreements.
UK company incorporated in 2016 provides international supply chain services to companies/organisations related to the pharmaceutical industry. The company is licensed by the UK Medicines and Healthcare Regulatory Agency (MHRA) and acts in accordance with the Good Distribution Practice (GDP).
The company provides secure access to international markets including the UK, France, Germany, and The Netherlands, and the Latin American market including Brazil, Mexico, Argentina, Colombia, Uruguay. The company has a particularly strong and reputable position in the Brazilian pharmaceutical market. This puts them in a unique position to be able to provide support accessing this expanding pharmaceutical market. The company is also able to assist pharmaceutical companies with delivering Early Access Programs (EAP's) to patients who have exhausted all approved medicines currently available. This would need to be authorised by the physician responsible for the patient.
The company has developed outstanding relationships with manufacturers and suppliers globally. The UK company facilitates international transport services for safeguarding and preserving the conservation characteristics of each medicine including providing controlled temperature or cold chain logistics management. The UK company only uses logistic operators specialising in special drugs and biological materials.
The company has experience working with medicines related to the prevention and treatment for cancer and rare diseases but is also happy to explore opportunities with other types of pharmaceutical companies that have commercially approved medicines.
Advisory support can also be provided in relation to customs clearance processes when necessary, for international trade activities.
As part of a commercial agency agreement, the UK company will be able to provide holistic support pharma companies that want to enter new markets.
- Type of partner sought: The UK company is interested in working with pharmaceutical companies who need assistance launching new medicinal products in the global market. This includes Early Access Programs as well.
- Specific area of activity of the partner: The UK company is interested in working with pharmaceutical companies who need assistance in launching new medicinal products in the global market. This includes Early Access Programs as well. The partnership is envisaged under a commercial agency agreement.
The company has access to the global market and is part of a leading pharmaceutical distribution group with bases in Brazil, USA as well as London.
Their presence in Brazil and other Latin American countries is particularly strong. The pharmaceutical market is expanding in this region and there is a particular demand for oncology products.
The UK company offers a holistic service and is in a position to support a potential partner with all aspects of the supply chain including strategic consultancy and the early access programs which allow a pharmaceutical company the opportunity to develop a customer base, receive valuable feedback before undertaking a large scale launch of the product in the local market.
The company has a storage facility within a licensed pharmaceutical warehouse in Brazil. This facility would be appropriate for companies including manufacturers that are intending to register their products within Brazil and supply the market.
Already on the market
24 days ago - PREPARE FOR BREXIT - Free events & webinars
24 days ago - Funding competition: ISCF Future food production systems
34 days ago - Innovation loans: September 2019 open competition